20/20 Onsite’s Post

Unlock the secrets to successful ophthalmology clinical operations with First in Human: The Panel Series. Hear from leading experts on collaboration, protocol development, and overcoming trial challenges. Watch here: https://lnkd.in/d2Xh-8TZ

🔍👁️ Diving deep into the science of ophthalmology with Dr. Prof. Marion Munk, M.D., Ph.D at European Society of Retina Specialists (EURETINA) 2024! This year, Dr. Munk highlights a crucial aspect of clinical research: the quest for reliable endpoints that truly reflect patient outcomes. 📊 Amidst discussions on the latest therapies and innovations, Dr. Munk stresses the importance of understanding the correlation between morphological changes and functional vision improvements. The challenge? Identifying effective biomarkers that not only track disease progression but also predict therapeutic efficacy. 🧩 Join us as Dr. Munk explores the complex relationship between structural markers and visual function, emphasizing the need for more nuanced approaches in evaluating treatment success. This conversation is especially pertinent as the ophthalmology community grapples with new therapy approvals and the quest for comprehensive patient care. #Euretina #Ophthalmology #EyeCare #RetinaSpecialist #MedicalInnovation #VisionHealth #EyeHealth #DigitalHealth #Retina #Ophthalmology #ClinicianLinkLive 

New partnership in eye care! Read our article here https://lnkd.in/gHPmNR2v to learn how Bausch + Lomb and Character Biosciences are teaming up to rewrite the playbook for age-related macular degeneration (AMD). This collaboration combines Bausch + Lomb's decades of expertise in ophthalmology with Character Bio's innovative data platform and AI-driven analytics to bring personalized therapies for AMD patients. #Ophthalmology #AMD #BauschandLomb #PIEMagazine #MediaMICE

Watch a short presentation of our CEO explaining how @NovaSight is planning to fight the myopia epidemic 🤓

Please take a look at the video below on Why Advancing Inclusive Research Matters in Ophthalmology Studies. Share it with family and friends. It is important that we educate ourselves and be part of the solutions. #inclusiveresearch #getinvolved

New Publication: VEGF-C and -D Signaling Pathways as Potential Targets for the Treatment of Wet AMD In this month’s edition of Ophthalmology and Therapy, a scientific review was published about the growing body of evidence that in retinal diseases, such as wet AMD, the pathophysiology is broader than simply dysregulation or overproduction of VEGF-A. Despite the tremendous progress in standard-of-care intravitreal anti-VEGF-A agents, visual gains can be limited in some wet AMD patients, as shown by clinical and real-world studies.  We want to recognize and thank the authors; Ian Leitch Mike Gerometta David Eichenbaum Robert Finger Nathan Steinle Megan Baldwin To read full peer-review article:  https://lnkd.in/eu2-_Bdt Christopher Vautrinot Springer Nature Group Springer Healthcare #Opthea #maculardegeneration #AMDResearch #wetAMD #ophthalmology #medicaleducation #biopharma #eyehealth #retinaspecialists #sozinibercept

Did you know that NaturalVue® Enhanced Multifocal 1 Day Contact Lenses may be effective for myopic patients with astigmatism? VTI’s Executive Director of Medical Affairs, Dr. Doug Benoit, says the reason for this comes from the lens design. “The NaturalVue Multifocal lens has a catenary curve-based design, which has a rapid increase in plus power, and that creates a very long and thin extended depth of focus channel,” said Dr. Benoit. “NaturalVue Multifocal can correct any astigmatism that falls along the extended depth of focus channel based on published clinical data.”¹˒² To further understand how NaturalVue® helps address astigmatism, Review of Myopia Management reached out to three practitioners — Dr. Elise Kramer, Dr. Jonathan Chen, and Dr. Jeffrey Cooper. Read about their experiences in this recent: https://lnkd.in/eYUhvTzp #VTI #NaturalVueEnhancedMultifocal #Astigmatism 1. Cooper J, O'Connor B, Aller T, Dillehay SM, Weibel K, Benoit D. Reduction of Myopic Progression Using a Multifocal Soft Contact Lens: A Retrospective Cohort Study. Clin Ophthalmol. 2022 Jul 4;16:2145-2155. 2. Lederman, CR. Myopia Control With Extended Depth of Focus Multifocal Contact Lenses. In: American Association for Pediatric Ophthalmology and Strabismus; 2023 Mar 29; New York, USA. MKT-VTI-SM54 r5

"𝑾𝒊𝒕𝒉𝒐𝒖𝒕 𝒑𝒂𝒕𝒊𝒆𝒏𝒕𝒔, 𝒕𝒉𝒆𝒓𝒆 𝒂𝒓𝒆 𝒏𝒐 𝒏𝒆𝒘 𝒄𝒍𝒊𝒏𝒊𝒄𝒂𝒍 𝒔𝒕𝒖𝒅𝒊𝒆𝒔. 𝑾𝒊𝒕𝒉𝒐𝒖𝒕 𝒏𝒆𝒘 𝒄𝒍𝒊𝒏𝒊𝒄𝒂𝒍 𝒔𝒕𝒖𝒅𝒊𝒆𝒔, 𝒕𝒉𝒆𝒓𝒆 𝒂𝒓𝒆 𝒏𝒐 𝒏𝒆𝒘 𝒅𝒓𝒖𝒈𝒔. 𝑨𝒏𝒅 𝒘𝒊𝒕𝒉𝒐𝒖𝒕 𝒏𝒆𝒘 𝒅𝒓𝒖𝒈𝒔, 𝒘𝒆 𝒄𝒂𝒏'𝒕 𝒃𝒓𝒊𝒅𝒈𝒆 𝒕𝒉𝒆 𝒈𝒂𝒑 𝒘𝒊𝒕𝒉 𝒉𝒆𝒂𝒍𝒕𝒉 𝒅𝒊𝒔𝒑𝒂𝒓𝒊𝒕𝒊𝒆𝒔 𝒕𝒉𝒂𝒕 𝒘𝒆 𝒉𝒂𝒗𝒆 𝒊𝒏 𝒐𝒖𝒓 𝒄𝒐𝒎𝒎𝒖𝒏𝒊𝒕𝒚." —𝑬𝒔𝒎𝒆𝒍 𝑴𝒆𝒆𝒌𝒔, 𝑫𝒊𝒓𝒆𝒄𝒕𝒐𝒓 𝒐𝒇 𝑺𝒊𝒈𝒉𝒕 𝑭𝒐𝒓𝒆𝒗𝒆𝒓, 𝑴𝒂𝒓𝒌𝒆𝒕𝒊𝒏𝒈 𝒂𝒏𝒅 𝑪𝒐𝒎𝒎𝒖𝒏𝒊𝒄𝒂𝒕𝒊𝒐𝒏𝒔, 𝑾𝒂𝒈𝒏𝒆𝒓 𝑲𝒂𝒑𝒐𝒐𝒓 𝑰𝒏𝒔𝒕𝒊𝒕𝒖𝒕𝒆 Please watch and share this patient and HCP educational video, Why Advancing Inclusive Research Matters in Ophthalmology Studies, to understand the importance of inclusive research. Diverse representation in clinical research is essential to examine how investigational medicines may improve our understanding of science. Patients, physicians, researchers, and community education experts at Retina Consultants of Texas, Charles Retina Institute in Tennessee, and Wagner Kapoor Institute in Virginia, and collaborated with the Genentech Advancing Inclusive Research Site Alliance and the Bravo Group to create this educational video. https://lnkd.in/gjqWbfvq

At Lexitas, we recognize the importance of shedding light on dry eye disease, a condition that affects millions worldwide. Our dedicated team is committed to advancing research for the development of innovative treatments to enhance the quality of life for those with dry eye. 🔹 Why It Matters: Dry eye can significantly impact daily life, causing discomfort, vision problems, and reduced productivity. 🔹 Our Commitment: With our extensive expertise in ophthalmology, Lexitas is at the forefront of clinical trials focused on new therapies for dry eye. Our goal is to help bring cutting-edge treatments to market faster, improving outcomes for patients everywhere. While innovative treatments do exist, it's imperative to continue bringing forth new products to meet all patient needs. Reach out to learn more about our dry eye expertise and how our teams can support your product development! ➡ https://lnkd.in/gAsDreUF #DryEyeAwarenessMonth #Ophthalmology #ClinicalTrials #ClinicalResearch #Lexitas #EyeHealth #InnovationInEyeCare

Ophthalmology Instrumentation Market Overview Visti Us- https://lnkd.in/e4fDCK6K The Ophthalmology Instrumentation market is growing due to the rising prevalence of eye disorders, an aging population, and advancements in surgical technologies. These instruments are critical for diagnosing and treating eye diseases such as cataracts, glaucoma, and macular degeneration. Market growth is driven by the increasing demand for eye care and technological innovations in instrumentation. Leading players in the market include ZEISS Group, AbbVie, Novartis, Alcon, Topcon Healthcare, and others. #EyeCare #Ophthalmology #MedicalDevices #HealthcareInnovation #VisionCare